Medcaw Investments Plc Directorate Change

 
TIDMMCI 
 
3rd March 2023 
 
                      Medcaw Investments Plc - 13078596 
                   ("Medcaw Investments" or the "Company") 
 
                                Board Changes 
 
Medcaw Investments Plc (LSE:MCI), a special purpose acquisition vehicle, 
announces that it has appointed Mr Charles Ainslie ("Charlie") Wood and Marcus 
Yeoman as Non-executive Directors of the Company with immediate effect, 
furthermore Daniel Maling and Fungai Ndoro have stepped down from the Board of 
the Company to focus on other projects. The Company would like to thank Daniel 
and Fungai for their contribution whilst on the Board and would like to wish 
them all the best in their future endeavours. All director fees will be 
deferred until the transaction between Medcaw and ATC is completed. Marcus 
Yeoman holds 0.18% and Charles Wood holds 6.16% of Medcaw Investments. 
 
Charlie Wood is a highly experienced senior corporate finance executive with 
wide ranging international and capital markets experience. Mr Wood is a Partner 
of Orana Corporate LLP, a London based FCA regulated corporate advisory and 
accounting practise working with innovative fast growth companies. In addition, 
Mr Wood holds various non-executive directorships in listed and private 
companies across natural resources, technology and FMCG. 
 
Marcus Yeoman is Chairman and Non-Executive director number of private 
companies which have engaged him principally to assist them with their growth 
strategies. His early career started with the formation of three companies in 
IT infrastructure and distribution, after which he moved into small company 
broking and corporate work with Rathbone Stockbrokers Limited and Cheviot 
Capital (Nominees) Limited. In 2003, Marcus established Springtime Consultants 
Ltd and has been acting as a consultant or Non-Executive Director to a number 
of listed companies and SME ventures over the 20 years. 
 
Further disclosures on Mr Wood and Marcus Yeoman as required pursuant to the 
FCA LR 9.6.11 Rulebook are included in the Appendix below. 
 
This announcement contains inside information for the purposes of UK Market 
Abuse Regulation. 
 
The persons who arranged the release of this information are the Directors of 
the Company. 
 
                                 *** ENDS *** 
 
Enquiries: 
 
Medcaw Investments Plc +44 (0)203 918 8797 
 
Sarah Cope, Executive Chairperson 
 
Arden Partners Plc       +44 (0) 2076 145 926 
 
Ruari McGirr 
 
Alexandra Campbell-Harris 
 
Appendix 
 
The following information is disclosed in respect of Mr Charles Ainslie Wood 
(age 48) pursuant to pursuant to Rule 4.9 of the FCA LR 9.6.11 Rulebook. All 
information is as at the date of this announcement. 
 
Current Directorships / Partnerships: 
 
Ainslie Capital Limited 
 
Critical Flow Tech UK Ltd 
 
ETI Ventures plc 
 
Hyperion Resources Ltd (prev. Hyperion CJT Investments Ltd 
 
Global Corporation) 
 
Leintwardine pty Ltd 
 
Longview Energy Limited 
 
Medcaw Technologies Limited 
 
Metallea Limited (prev. Hyperion 
 
Orana Corporate LLP 
 
Supernatural Food Limited 
 
Tasmania Vodka Ltd 
 
Woodell Investments pty Ltd 
 
Past Directorships / Partnerships (within the last five years): 
 
Basin Energy One plc 
 
Attis Oil and Gas Limited 
 
Black Swan Resources plc 
 
Brand Sheild Systems plc (prev. Two Shields Investments plc) 
 
Deloro Energy LLP 
 
East Star Resources plc 
 
Euro SI ltd 
 
Helium One (UK) Limited (prev. Attis Oil & Gas (UK) Limited) 
 
Helium Ventures plc 
 
Metals One plc 
 
Suboceanic plc 
 
Suboceanic Group 
 
Thrivanta Investments plc 
 
Zarmandan Gold Limited 
 
Mr Wood was a director of Euro SI Ltd which was dissolved by way of a 
creditors' voluntary wind-up at the time of or in the 12 months following his 
resignation as a director. 
 
Mr Wood was a director of Commodities Finance Limited that was dissolved via a 
voluntary strike-off at the time of or in the 12 months following his 
resignation as a director. 
 
Mr Wood has an interest in 1,056,000 ordinary shares and a warrant to subscribe 
for 844,800 ordinary shares in the Company, totalling 6.16% of holdings. 
 
The following information is disclosed in respect of Mr Marcus Yeoman (age 59) 
pursuant to pursuant to the FCA LR 9.6.11 Rulebook. All information is as at 
the date of this announcement. 
 
Current Directorships / Partnerships: 
 
Tower Green Holding (14254478) 
 
Kipling House Investments Limited (13498851) 
 
Widetek Limited (12273039) 
 
Hancock Scotland Limited (SC591337)Springtime Consultants(04657744) 
 
Storyboard Assets Plc (06436259) 
 
Peter Nicholson Films (07353933)Oneline Films Ltd (09133685) 
 
Past Directorships / Partnerships (within the last five years): 
 
Online Films Ltd (09133685) 
 
R4E Limited(07841406) 
 
Newman Displays Limited (02250991) 
 
Dewynters Limited (00197585) 
 
Miroma Set Limited (02725009) 
 
Melrose and Morgan (05085202) 
 
Intosol Holdings Plc (10806039) 
 
Mr Yeoman has an interest in 30,900 ordinary shares in the company, totalling 
0.18% of holdings. 
 
 
 
END
(END) Dow Jones Newswires
March 06, 2023 04:39 ET (09:39 GMT)
Medcaw Investments (LSE:MCI)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024